Evaluating the Efficacy and Safety of Dolutegravir-Containing Versus Efavirenz-Containing Antiretroviral Therapy Regimens in HIV-1-Infected Pregnant Women and Their Infants
Clinical trial NCT03048422 · COMPLETED
Trial details
- NCT number
- NCT03048422
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-19
- Primary completion
- 2020-10-03
- Enrollment
- 643
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.